Biosynthesis of drug metabolites using microbes in hollow fiber cartridge reactors: Case study of diclofenac metabolism by actinoplanes species

Drug Metabolism and Disposition

Volumn 36, Issue 2, 2008, Pages 234-240

  Osorio Lozada, Antonio ^a,b   Surapaneni, Sekhar ^a,c   Skiles, Gary L ^a   Subramanian, Raju ^a  

^a AMGEN INC   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c CELGENE CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DICLOFENAC; DRUG METABOLITE; POLITEF; POLYSULFONE;

ACTINOMYCES; ARTICLE; BIOTRANSFORMATION; DRUG METABOLISM; DRUG SYNTHESIS; INCUBATION TIME; MICROORGANISM; NONHUMAN; PRIORITY JOURNAL;

ACTINOBACTERIA; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BIOREACTORS; BIOTRANSFORMATION; DICLOFENAC; FUNGI; HYDROXYLATION;

ACTINOPLANES; ACTINOPLANES SP.; BACTERIA (MICROORGANISMS); MAMMALIA;

EID: 38749150603     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.107.019323     Document Type: Article

References (23)

1. Bort R, Ponsoda X, Carrasco E, Gomez-Lechon MJ, and Castell JV (1996) Metabolism of aceclofenac in humans. Drug Metab Dispos 24:834-841.
2. Chen TS, So L, White R, and Monaghan RL (1993) Microbial hydroxylation and glucuronidation of the angiotensin II receptor antagonist MK 954. J Antibiot 46:131-134.
3. Goodhue CT (1982) The methodology of microbial transformations of organic compounds, in Microbial Transformations of Bioactive Compounds (Rosazza JP ed) vol 1, pp 9-44, CRC Press, Boca Raton.
4. Haag M, Baumann K, Billich A, Bulusu M, Fehr T, Grassberger M, Haidl E, Schulz G, and Sanglier J (1998) Bioconversion of ascomycin and its 6-alkoxy derivatives. J Mol Catal, B Enzym 5:389-394.
5. Hilton MD (1999) Small scale liquid fermentations, in Manual of Industrial Microbiology and Biotechnology (Atlas RM et al., eds) pp 49-60, ASM Press, Washington, DC.
6. Hsu FL, Hou CC, Yang LM, Cheng JT, Chi TC, Liu PC, Lin SJ (2002) Microbial transformations of isosteviol. J Nat Prod 65:273-277.
7. Inloes DS, Taylor DP, Cohen SN, Michaels AS, and Robertson CR (1983) Ethanol production by Saccharomyces cerevisiae immobilized in hollow-fiber membrane bioreactors. Appl Environ Microbiol 46:264-278.
8. Kan JK and Shuler ML (1978) Urocanic acid production using whole cells immobilized in a hollow fiber reactor. Biotechnol Bioeng 20:217-230.
9. Kenny JR, Maggs JL, Meng X, Sinnott D, Clarker SE, Kevin Park B, and Stachulski AV (2004) Synthesis and characterization of the acyl glucuronide and hydroxyl metabolites of diclofenac. J Med Chem 47:2816-2825.
10. Knazek RA, Gullino PM, Kohler PO, and Dedrick RL (1972) Cell culture on artificial capillaries: an approach to tissue growth in vitro. Science 178:65-66.
11. Kuhnt M, Bitsch F, France J, Hofmann H, Sanglier JJ, Traber R (1996) Microbial biotransformation products of Cyclosporin A. J Antibiot 49:781-787.
12. TB (CYP2C): a major monooxygenase catalyzing diclofenac 4′-hydroxylation in human liver. Life Sci 52:29-34.
13. Leon R, Prazeras DMF, Fernandes P, Molinari F, and Cabral JMS (2001) A multiphasic hollow fiber reactor for the whole cell bioconversion of 2-methyl-1,3-propanediol to (R)-β-hydroxyisobutyric acid. Biotechnol Prog 17:468-473.
14. Rushmore TH, Reider PJ, Slaughter D, Assang C, and Shou M (2000) Bioreactor systems in drug metabolism: synthesis of cytochrome P450-generated metabolites. Metab Eng 2:115-125.
15. Shen S, Marchick MR, Davis MR, Doss GA, and Pohl L (1999) Metabolic activation of diclofenac by human cytochrome P450 3A4: role of 5-hydroxydiclofenac. Chem Res Toxicol 12:214-222.
16. Smith RV and Rosazza JP (1974) Microbial models of mammalian metabolism. Aromatic hydroxylation. Arch Biochem Biophys 161:551-558.
17. So L, White R, Petuch B, Schwartz MS, Cheng H, Monaghan R, Chen TS (1995) Microbial transformation of N-heptyl physostigmine, a semisynthetic alkaloid inhibitor of cholinesterase. J Ind Microbiol 15:108-111.
18. Stierlin H, Faigle JW, Sallmann A, and Kung W (1979) Biotransformation of diclofenac sodium (Voltaren) in animals and in man. I. Isolation and identification of principal metabolites. Xenobiotica 9:601-610.
19. Tang W, Stearns RA, Bandeira SM, Zhang Y, Raab C, Braun MP, Dean DC, Pang J, Leung KH, Doss GA, et al. (1999) Studies on cytochrome P-450-mediated bioactivation of diclofenac in rats and in human hepatocytes: identification of glutathione conjugated metabolites. Drug Metab Dispos 27:365-372.
20. Vail RB, Homann MJ, Hanna I, and Zaks A (2005) Preparative synthesis of drug metabolites using human cytochrome P450s 3A4, 2C9, and 1A2 with NADPH-P450 reductase expressed in E. Coli. J Ind Microbiol Biotechnol 32:67-74.
21. Webster R, Pacey M, Winchester T, Johnson P, and Jezequel S (1998) Microbial oxidative metabolism of diclofenac: production of 4′- hydroxydiclofenac using Epiccocum nigrum IMI354292. Appl Microbiol Biotechnol 49:371-376.
22. Zhang D, Hanson R, Roongta V, Dischino DD, Gao Q, Sloan CP, Polson C, Keavy D, Zheng M, Mitroka J, et al. (2006) In vitro and in vivo metabolism of a gamma-secretase inhibitor BMS-299897 and generation of active metabolites in milligram quantities with a microbial bioreactor. Current Drug Metabolism 7:883-896.
23. Zmijewski M, Gillespie TA, Jackson DA, Schmidt DF, Yi P, and Kulanthaivel P (2006) Application of biocatalysis to drug metabolism: preparation of mammalian metabolites of a bisaryl-bis-sulfonamide AMPA receptor potentiator using Actinoplanes missourensis. Drug Metab Dispos 34:925-931.